Zepp Health Corporation
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.1% | 65.3% | 63.2% | 59.7% | 59.4% | 63.2% | 62.7% | 63.8% | 61.8% | 59.0% | 61.3% | 61.9% | 60.9% | |
| 33.9% | 34.7% | 36.8% | 40.3% | 40.6% | 36.8% | 37.3% | 36.2% | 38.2% | 41.0% | 38.7% | 38.1% | 39.1% | |
| 12.4% | 13.4% | 33.6% | 26.6% | 25.6% | 18.6% | 32.1% | 18.8% | 14.3% | 12.9% | 21.7% | 18.2% | 16.1% | |
| 8.0% | 6.2% | 15.9% | 1.6% | 2.4% | 4.6% | 2.3% | 7.5% | 9.2% | 4.6% | 6.7% | 5.6% | 6.5% | |
| 32.1% | 34.0% | 76.6% | 64.5% | 70.1% | 51.8% | 84.9% | 46.4% | 39.3% | 45.5% | 73.0% | 57.5% | 51.6% | |
| 1.8% | 0.8% | -39.4% | -24.3% | -29.5% | -15.0% | -47.7% | -10.3% | -1.2% | -4.5% | -34.3% | -19.4% | -12.4% | |
| 1.9% | 1.7% | 3.6% | 3.4% | 3.0% | 2.4% | 3.5% | 2.1% | 2.0% | 1.9% | 3.2% | 2.6% | 2.3% | |
| 0.5% | 1.8% | -36.9% | -26.6% | -31.2% | -39.2% | -50.9% | -12.6% | -2.0% | -10.5% | -37.7% | -17.7% | -14.7% | |
| 0.1% | 3.3% | 0.2% | 0.1% | 0.2% | 22.8% | 0.3% | 0.4% | 0.2% | 2.4% | 0.4% | 0.2% | 0.9% | |
| 0.5% | -1.5% | -37.0% | -26.7% | -31.2% | -62.0% | -51.2% | -13.0% | -2.1% | -12.9% | -38.1% | -17.8% | -15.6% | |
| 2.5% | 1.3% | -31.9% | -22.4% | -27.1% | -31.0% | -46.5% | -8.5% | 1.2% | -8.6% | -34.5% | -19.4% | -13.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.